Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, AntagomiR-based therapy for T2DM: MiRNA-4500 promotes glucose intolerance and insulin resistance via down regulation of its target gene, 10/February/2015, 23.16, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Significance: This study suggests, for the first time, that MiRNA-4500, by suppressing the expression of its target gene, it may promote glucose intolerance and insulin resistance. Thus, pharmacological formulations encompassing “miRNA-4500 inhibitors“ may be used to inhibit glucose intolerance and insulin resistance and promote insulin sensitivity.
Amount: $ 300*
Undisclosed information: How miRNA-4500 inhibits glucose intolerance and insulin resistance
Web: http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
